Active	Status	Sponsor type	Region	Phase	Filter
13 Active 4 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cheung, Anson
TIARA-I, NCT02276547: Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System	Active, not recruiting	N/A	27	Europe, Canada, US	Mitral valve replacement, TIARA Mitral Transcatheter Heart Valve, TIARA Transapical Delivery System	Neovasc Inc.	Mitral Valve Regurgitation	01/20	02/25
NCT03616678: VenTouch OUS Feasibility Study	Recruiting	N/A	15	Europe, Canada, RoW	VenTouch System	Mardil Medical	Functional Mitral Regurgitation	05/21	12/23
Viklicky, Ondrej
FALCON, NCT03918447 / 2018-004651-20: A Trial of Bardoxolone Methyl in Patients With ADPKD -	Terminated	3	667	Europe, Japan, US, RoW	Bardoxolone methyl oral capsule, RTA 402, Placebo oral capsule	Reata, a wholly owned subsidiary of Biogen, Reata Pharmaceuticals, Inc., REATA PHARMACEUTICALS, INC	Autosomal Dominant Polycystic Kidney, ADPKD	08/23	08/23
IMAGINE, NCT03744910 / 2018-003682-34: Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients	Terminated	3	194	Europe, Canada, US, RoW	Clazakizumab, Physiologic saline solution	CSL Behring, ICON Clinical Research	Antibody-mediated Rejection	04/24	04/24
NCT06274489: A Study to Evaluate Setanaxib in Patients With Alport Syndrome	Active, not recruiting	1/2	18	Europe, RoW	Setanaxib, Placebo	Calliditas Therapeutics AB	Alport Syndrome	01/25	01/25
DEFILE, NCT06476717: Donor-derived Cell-free DNA in Kidney Transplant Recipients	Active, not recruiting	N/A	143	RoW	Biopsy, Blood Biomarkers - cfDNA, dd-cfDNA, Antirejection therapy	Institute for Clinical and Experimental Medicine, Natera, Inc.	Kidney Transplantation, Acute Rejection of Renal Transplant	05/24	12/24
NCT04239703: Trifecta-Kidney cfDNA-MMDx Study	Recruiting	N/A	300	Europe, Canada, US, RoW	MMDx, Prospera, transplant patient blood sample, HLA antibody	University of Alberta, Natera, Inc., One Lambda	Kidney Transplant Rejection	12/25	12/26
Mok, Catherin
NCT03616678: VenTouch OUS Feasibility Study	Recruiting	N/A	15	Europe, Canada, RoW	VenTouch System	Mardil Medical	Functional Mitral Regurgitation	05/21	12/23